EP 1339404 A2 20030903 - COMPOSITION AND METHOD
Title (en)
COMPOSITION AND METHOD
Title (de)
ZUSAMMENSETZUNG UND VERFAHREN
Title (fr)
COMPOSITION ET METHODE
Publication
Application
Priority
- US 0148665 W 20011030
- US 24451100 P 20001031
- US 25344700 P 20001128
- US 25344600 P 20001128
- US 92263301 A 20010806
Abstract (en)
[origin: WO0243666A2] A composition comprising an antioxidant or mixture thereof in quantities sufficient to prevent, or inhibit, or reverse deterioration of cognitive function.
IPC 1-7
IPC 8 full level
A61K 45/00 (2006.01); A23K 1/16 (2006.01); A23K 1/18 (2006.01); A61K 31/197 (2006.01); A61K 31/34 (2006.01); A61K 31/355 (2006.01); A61K 31/375 (2006.01); A61K 31/381 (2006.01); A61K 31/385 (2006.01); A61K 45/08 (2006.01); A61P 25/28 (2006.01)
CPC (source: EP)
A23K 20/142 (2016.05); A23K 20/158 (2016.05); A23K 50/40 (2016.05); A61K 31/34 (2013.01); A61K 31/355 (2013.01); A61K 31/385 (2013.01); A61P 25/28 (2017.12)
Citation (search report)
See references of WO 0243666A2
Citation (examination)
M.H. BEERS, R. BERKOW: "The Merck Manual of Diagnosis and Therapy, Seventeenth Edition", 1999, MERCK RESEARCH LABORATORIES, WHITEHOUSE STATION, N.J.
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0243666 A2 20020606; WO 0243666 A3 20030130; AU 3261602 A 20020611; CA 2427470 A1 20020606; CN 1477958 A 20040225; EP 1339404 A2 20030903; JP 2004514686 A 20040520
DOCDB simple family (application)
US 0148665 W 20011030; AU 3261602 A 20011030; CA 2427470 A 20011030; CN 01818188 A 20011030; EP 01992146 A 20011030; JP 2002545645 A 20011030